Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Research & Development (2016)

MedWellAI (MWAI) has disclosed Research & Development for 2 consecutive years, with $738.0 as the latest value for Q4 2016.

  • On a quarterly basis, Research & Development fell 63.48% to $738.0 in Q4 2016 year-over-year; TTM through Dec 2016 was $17595.0, a N/A change, with the full-year FY2017 number at $21636.0, down 82.0% from a year prior.
  • Research & Development was $738.0 for Q4 2016 at MedWellAI, down from $894.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $13942.0 in Q1 2016 to a low of $738.0 in Q4 2016.